ACTIVE

BIONCISE

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-29,5 k €

-210.1% YoY

Gross margin

125,4 k €

-23.5% YoY

Equity

172,5 k €

-14.6% YoY

What does BIONCISE do?

BIONCISE is a Public limited company incorporated in 2017. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Wellen.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0671.983.435

Incorporation

02/03/2017

Legal form

Public limited company

Registered office

Bodemstraat 16 box 3
3830 Wellen · FlandreSee on map

Contributed capital

320 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

32500Manufacture of medical and dental instruments and supplies· main 32500Manufacture of medical and dental instruments and supplies 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores+2

Joint committees (2)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 8 financial years

	2025		2024		2023		2022		2021		2020		2019		2018
Income statement
Gross margin	125,4 k €	-23.5%	164 k €	-48.6%	318,9 k €	+353%	-126 k €	-137%	343,9 k €	+874%	-44,5 k €	-132%	137,5 k €	-16.3%	164,3 k €
EBITDA	4,2 k €	-93.9%	69,6 k €	-64.3%	194,8 k €	+187%	-223,6 k €	-191%	244,4 k €	+295%	-125,6 k €	-282%	69,1 k €	+221%	-57 k €
Operating result	-29,6 k €	-189%	33,4 k €	-79.0%	159,1 k €	+161%	-259,5 k €	-225%	207,6 k €	+228%	-161,6 k €	-539%	36,8 k €	+136%	-101,8 k €
Net result	-29,5 k €	-210%	26,8 k €	-77.5%	119,2 k €	+150%	-240,7 k €	-216%	207,9 k €	+230%	-160,3 k €	-541%	36,4 k €	+136%	-100,3 k €
Balance sheet
Equity	172,5 k €	-14.6%	202 k €	+15.3%	175,2 k €	+213%	56 k €	-81.1%	296,7 k €	+234%	88,8 k €	-64.4%	249,1 k €	+13.4%	219,7 k €
Total assets	242,8 k €	-8.9%	266,5 k €	-13.1%	306,5 k €	-30.5%	440,8 k €	-45.7%	811,6 k €	+32.2%	613,8 k €	-21.8%	784,5 k €	-7.4%	847,3 k €
Cash	68,8 k €	+66.3%	41,4 k €	+78.4%	23,2 k €		–		144,2 k €	+72.1%	83,8 k €	-51.4%	172,4 k €	-5.5%	182,4 k €
Debts	70,3 k €	+9.0%	64,5 k €	-50.9%	131,3 k €	-65.9%	384,8 k €	-25.1%	513,7 k €	-2.2%	525 k €	-1.9%	535,4 k €	-14.7%	627,6 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 5 ended

Active mandates

Jacques Janssens

Mandate

Active

Johan Janssens

Mandate

Active

Magda Buttiens

Mandate

Active

Ended mandates

Johan Janssens

Director · since 10 août 2020 · until 19 juin 2026

Ended

Dokter Janssens Jacques

Director · since 27 septembre 2017 · until 21 juin 2024 · 0824.062.906

Represented by Jacques Janssens

Ended

Jacques Janssens

Managing director · since 27 septembre 2017 · until 21 juin 2024

Ended

Magda Buttiens

Director · since 27 septembre 2017 · until 21 juin 2024

Ended

At this address

Other companies at this address

Company	CBE no.
V&B-DAKWERKEN● Active	0649.804.087

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/07/2026	28/07/2025	30/09/2024	06/10/2023	28/07/2022	31/08/2021
General meeting	19/06/2026	30/06/2025	30/06/2024	16/06/2023	17/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

9 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	19/06/2026	13/07/2026	Dutch	PDF
Micro model	31/12/2024	30/06/2025	28/07/2025	Dutch	PDF
Micro model	31/12/2023	30/06/2024	30/09/2024	Dutch	PDF
Micro model	31/12/2022	16/06/2023	06/10/2023	Dutch	PDF
Micro model	31/12/2021	17/06/2022	28/07/2022	Dutch	PDF
Micro model	31/12/2020	18/06/2021	31/08/2021	Dutch	PDF
Micro model	31/12/2019	10/08/2020	13/08/2020	Dutch	PDF
Micro modelCorrection	31/12/2018	21/06/2019	19/09/2019	Dutch	PDF
Micro model	31/12/2018	21/06/2019	26/07/2019	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 5 ended

Active mandates

Jacques Janssens

Mandate

Active

Johan Janssens

Mandate

Active

Magda Buttiens

Mandate

Active

Ended mandates

Johan Janssens

Director · since 10 août 2020 · until 19 juin 2026

Ended

Dokter Janssens Jacques

Director · since 27 septembre 2017 · until 21 juin 2024 · 0824.062.906

Represented by Jacques Janssens

Ended

Jacques Janssens

Managing director · since 27 septembre 2017 · until 21 juin 2024

Ended

Magda Buttiens

Director · since 27 septembre 2017 · until 21 juin 2024

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates04/03/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/09/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/01/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/01/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares20/11/2017
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other06/03/2017
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-29,5 k €↓
2024
Annual accounts 202426,8 k €↓
2023
Annual accounts 2023119,2 k €↑
2022
Annual accounts 2022-240,7 k €↓
2021
Annual accounts 2021207,9 k €↑
2020
Annual accounts 2020-160,3 k €↓
2019
Annual accounts 201936,4 k €↑
2018
Annual accounts 2018-100,3 k €
02/03/2017
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BIONCISE

Overview

What does BIONCISE do?

Trend over 8 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline